A biopharmaceutical company focused on innovative RNA-based therapeutics
| Year | Firm | Period | Expenses | Doc |
|---|---|---|---|---|
| 2026 | TARPLIN, DOWNS & YOUNG, LLC |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
— |
| Firm | Filings | Expenses |
|---|---|---|
| TARPLIN, DOWNS & YOUNG, LLC | 52 | — |
| Issue | Activities |
|---|---|
| Health Issues | 52 |
| Budget/Appropriations | 51 |
| Medicare/Medicaid | 48 |
| Copyright/Patent/Trademark | 10 |
| Pharmacy | 1 |